Fusion Biopsy
A Global Strategic Business Report
MCP31101
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Fusion Biopsy Market to Reach US$1.1 Billion by 2030
The global market for Fusion Biopsy estimated at US$714.6 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Transrectal Biopsy Route, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$640.9 Million by the end of the analysis period. Growth in the Transperineal Biopsy Route segment is estimated at 8.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$194.7 Million While China is Forecast to Grow at 10.3% CAGR
The Fusion Biopsy market in the U.S. is estimated at US$194.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$216.3 Million by the year 2030 trailing a CAGR of 10.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
Global Fusion Biopsy Market – Key Trends & Drivers Summarized
Why is Fusion Biopsy Revolutionizing Cancer Diagnostics?
Fusion biopsy has emerged as a groundbreaking advancement in cancer diagnostics, particularly in the detection of prostate cancer, due to its superior accuracy and ability to target suspicious lesions with precision. Unlike traditional biopsy methods, which rely solely on transrectal ultrasound (TRUS) imaging, fusion biopsy integrates magnetic resonance imaging (MRI) with real-time ultrasound to enhance lesion visualization and improve sampling accuracy. This combination significantly reduces the risk of false-negative results and unnecessary repeat biopsies, addressing a long-standing challenge in cancer diagnostics. Given the increasing prevalence of prostate cancer and the need for early and accurate detection, fusion biopsy is rapidly gaining adoption in leading hospitals, cancer centers, and diagnostic laboratories worldwide.
The growing awareness among healthcare providers about the limitations of conventional biopsy techniques has further fueled the demand for MRI-ultrasound fusion biopsy. Clinicians and researchers are increasingly advocating for its use in cases where PSA (prostate-specific antigen) levels are elevated but standard TRUS-guided biopsies yield inconclusive results. Additionally, advancements in imaging software and AI-driven diagnostic tools have enhanced the accuracy of lesion detection, making fusion biopsy a more reliable diagnostic tool for various forms of cancer, including kidney, liver, and breast malignancies. As precision medicine continues to evolve, the role of fusion biopsy in improving early cancer detection and personalized treatment planning is becoming more prominent.
How is Technology Enhancing the Accuracy and Efficiency of Fusion Biopsy?
Recent innovations in medical imaging and biopsy technology have significantly improved the efficiency and accuracy of fusion biopsy procedures. AI-powered image analysis has enhanced lesion detection capabilities, reducing the risk of sampling errors and improving diagnostic confidence. Real-time 3D imaging has further optimized the biopsy process by allowing clinicians to precisely map tumor locations and adjust needle trajectories accordingly. Additionally, robotic-assisted biopsy systems are being integrated with fusion biopsy platforms to increase precision, minimize patient discomfort, and reduce procedure time.
The development of cloud-based biopsy management software has also streamlined data storage, analysis, and remote collaboration among pathologists and oncologists. These digital platforms enable seamless sharing of biopsy results, facilitating multidisciplinary cancer care and second-opinion consultations. Moreover, the integration of machine learning algorithms into fusion biopsy systems is allowing for the automated identification of cancerous tissues, reducing the need for invasive repeat procedures. As the adoption of minimally invasive diagnostic techniques continues to grow, fusion biopsy is expected to become a standard of care in oncological diagnostics, replacing conventional biopsy methods that often yield inconclusive or unreliable results.
Which Medical Specialties and Healthcare Institutions Are Driving Demand for Fusion Biopsy?
Urology remains the primary medical specialty driving demand for fusion biopsy, as prostate cancer diagnosis accounts for the majority of its applications. Leading hospitals, specialty cancer clinics, and diagnostic imaging centers are actively investing in fusion biopsy systems to improve patient outcomes and reduce misdiagnosis rates. Additionally, academic research institutions and clinical trial organizations are utilizing fusion biopsy technology to study new biomarkers and evaluate targeted therapies, expanding its application beyond standard cancer diagnostics.
Beyond prostate cancer, the adoption of fusion biopsy is growing in nephrology, gastroenterology, and hepatology for the detection of kidney, liver, and pancreatic tumors. Breast cancer research is also benefiting from the technology, as fusion biopsy is enabling more precise tissue sampling in cases where mammographic and ultrasound findings are inconclusive. The expansion of telemedicine and remote diagnostics has further facilitated access to fusion biopsy expertise in underserved regions, where specialized oncological imaging was previously limited. With rising cancer incidence rates and increasing investments in advanced diagnostic technologies, the demand for fusion biopsy across multiple medical specialties is expected to surge.
What Key Factors Are Driving Market Growth?
The growth in the fusion biopsy market is driven by several factors, including advancements in imaging technology, increasing cancer incidence rates, and the growing emphasis on early and accurate diagnosis. The widespread adoption of AI-assisted imaging and robotic biopsy systems has improved procedural efficiency, reducing the likelihood of sampling errors and improving patient outcomes. Additionally, the expansion of telemedicine and cloud-based diagnostic platforms has made fusion biopsy more accessible to healthcare institutions worldwide, particularly in regions with limited oncological expertise.
Regulatory approvals for fusion biopsy devices and the integration of new biomarkers into diagnostic protocols are also fueling market expansion. The shift toward minimally invasive cancer diagnostics, coupled with rising investments in personalized medicine, has further strengthened the demand for fusion biopsy. Additionally, collaborations between medical device manufacturers, research institutions, and healthcare providers are accelerating the development of next-generation biopsy systems that enhance precision, automation, and AI-driven decision-making. As healthcare systems continue to prioritize early cancer detection, fusion biopsy is expected to play an increasingly pivotal role in the future of precision oncology.
SCOPE OF STUDY
The report analyzes the Fusion Biopsy market by the following Segments, and Geographic Regions/Countries:
Segments:
Biopsy Route (Transrectal Biopsy Route, Transperineal Biopsy Route); End-Use (Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Care Centers End-Uses).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
Artemis; Biobot Surgical; BK Medical; D&K Technologies; Eigen; Esaote; Focal Healthcare; GE Healthcare; Hitachi Medical Systems; innoMedicus; KOELIS; MedCom; Medtronic; Philips Healthcare; Profound Medical; Siemens Healthineers; SonaCare Medical; Toshiba Medical Systems Corporation; United Medical Systems; UroNav;
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Fusion Biopsy – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 43 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Prevalence of Prostate Cancer Drives Adoption of Fusion Biopsy for Accurate Diagnosis |
| Advancements in MRI and Ultrasound Integration Technologies Throw the Spotlight on Precision Biopsy Tools |
| Increased Focus on Minimally Invasive and Targeted Diagnostics Supports Growth of Fusion Biopsy Procedures |
| Clinical Evidence Supporting Improved Cancer Detection Rates With MRI/US Fusion Enhances Physician Confidence |
| Surge in Adoption of MRI-Visible Lesion Mapping Enables High-Precision Prostate Sampling |
| Expansion of Urology Clinics and Specialty Diagnostic Centers Fuels Market Access and Adoption |
| Growth in Medicare and Private Reimbursement Coverage Supports Procedural Volume |
| Integration of AI and Image-Guided Navigation Enhances Fusion Biopsy Accuracy and Workflow |
| Rising Demand for Outpatient Biopsy Solutions Promotes Use of Office-Based Fusion Systems |
| Development of Robotic and Semi-Automated Fusion Platforms Supports Standardization of Results |
| Global Awareness Campaigns on Early Detection of Prostate Cancer Encourage Patient Screening |
| Improved Patient Comfort and Reduced Complication Rates Drive Preference for Fusion Over TRUS-Only Biopsies |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Fusion Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Fusion Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Fusion Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Fusion Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Transrectal Biopsy Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Transrectal Biopsy Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Transrectal Biopsy Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Transperineal Biopsy Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Transperineal Biopsy Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Transperineal Biopsy Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Ambulatory Care Centers End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Ambulatory Care Centers End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Ambulatory Care Centers End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| JAPAN |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| CHINA |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| EUROPE |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Fusion Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Fusion Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Fusion Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| FRANCE |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| GERMANY |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Fusion Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Fusion Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Fusion Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| AUSTRALIA |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E) |
| Australia Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| INDIA |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E) |
| India Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| LATIN AMERICA |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E) |
| Latin America Recent Past, Current & Future Analysis for Fusion Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Fusion Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Fusion Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| MIDDLE EAST |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E) |
| Middle East Recent Past, Current & Future Analysis for Fusion Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Fusion Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Fusion Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
| AFRICA |
| Fusion Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E) |
| Africa Recent Past, Current & Future Analysis for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Fusion Biopsy by Biopsy Route - Transrectal Biopsy Route and Transperineal Biopsy Route Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Fusion Biopsy by Biopsy Route - Percentage Breakdown of Value Sales for Transrectal Biopsy Route and Transperineal Biopsy Route for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Fusion Biopsy by End-Use - Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Fusion Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use and Ambulatory Care Centers End-Uses for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]